Biodesix (BDSX) Insider Trading & Ownership $0.40 -0.05 (-10.40%) Closing price 04:00 PM EasternExtended Trading$0.40 0.00 (-0.37%) As of 05:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Biodesix (NASDAQ:BDSX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage30.10%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$393.50KNumber OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$127.92K Get BDSX Insider Trade Alerts Want to know when executives and insiders are buying or selling Biodesix stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BDSX Insider Buying and Selling by Quarter Biodesix Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/12/2025Chris VazquezCAOSell112$0.36$40.32 5/12/2025Gary Anthony PestanoInsiderSell223$0.36$80.28 5/12/2025Robin Harper CowieCFOSell496$0.36$178.56 5/12/2025Scott HuttonCEOSell1,888$0.36$679.68 2/11/2025Chris VazquezCAOSell3,630$0.92$3,339.60 2/11/2025Gary Anthony PestanoInsiderSell16,748$0.92$15,408.16 2/11/2025Robin Harper CowieCFOSell24,664$0.92$22,690.88 2/11/2025Scott HuttonCEOSell83,660$0.92$76,967.20 11/20/2024Jack W SchulerDirectorBuy200,000$1.17$234,000.00 11/5/2024John PatienceChairmanBuy75,000$1.38$103,500.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 11/5/2024Matthew StrobeckDirectorBuy40,000$1.40$56,000.00 8/12/2024Chris VazquezCAOSell54$1.57$84.78 8/12/2024Gary Anthony PestanoInsiderSell111$1.57$174.27 8/12/2024Robin Harper CowieCFOSell251$1.57$394.07 8/12/2024Scott HuttonCEOSell963$1.57$1,511.91 8/9/2024Chris VazquezCAOSell155$1.60$248.00 8/9/2024Gary Anthony PestanoInsiderSell320$1.60$512.00 8/9/2024Robin Harper CowieCFOSell724$1.60$1,158.40 8/9/2024Scott HuttonCEOSell2,781$1.60$4,449.60 (Data available from 1/1/2013 forward) BDSX Insider Trading Activity - Frequently Asked Questions Who is on Biodesix's Insider Roster? The list of insiders at Biodesix includes Chris Vazquez, Gary Anthony Pestano, Hany Massarany, Jack W Schuler, John Patience, Kieran O'kane, Matthew Strobeck, Robert William Georgantas III, Robin Harper Cowie, Ryan H Siurek, and Scott Hutton. Learn more on insiders at BDSX. What percentage of Biodesix stock is owned by insiders? 30.10% of Biodesix stock is owned by insiders. Learn more on BDSX's insider holdings. Which Biodesix insiders have been buying company stock? The following insiders have purchased BDSX shares in the last 24 months: Jack W Schuler ($437,016.84), John Patience ($103,500.00), and Matthew Strobeck ($56,000.00). How much insider buying is happening at Biodesix? Insiders have purchased a total of 435,056 BDSX shares in the last 24 months for a total of $596,516.84 bought. Which Biodesix insiders have been selling company stock? The following insiders have sold BDSX shares in the last 24 months: Chris Vazquez ($8,197.27), Gary Anthony Pestano ($37,778.11), Robin Harper Cowie ($62,922.45), and Scott Hutton ($217,055.24). How much insider selling is happening at Biodesix? Insiders have sold a total of 250,776 Biodesix shares in the last 24 months for a total of $325,953.07 sold. Biodesix Key ExecutivesMr. Scott Hutton (Age 52)President, CEO & Director Compensation: $614.92k2 recent tradesMs. Robin Harper Cowie (Age 44)CFO, Secretary & Treasurer Compensation: $390.3k2 recent tradesMr. Kieran O'Kane (Age 47)Chief Commercial Officer Compensation: $392.61kDr. Heinrich RöderFounder & CTOMr. Christopher VazquezVP, Controller & Chief Accounting OfficerMr. Mark DeBlockVice President of SalesMr. Robbie LuntSenior Director of MarketingMs. Jessica OlbrichtSenior Director of Human ResourcesDr. Gary Anthony Pestano Ph.D. (Age 57)Chief Development Officer Ms. Bobbi CoffinChief Growth Officer More Insider Trading Tools from MarketBeat Related Companies Viemed Healthcare Insider Ownership Exagen Insider Ownership DocGo Insider Ownership Sera Prognostics Insider Ownership Quipt Home Medical Insider Ownership P3 Health Partners Insider Ownership Marpai Insider Ownership Biorestorative Therapies Insider Ownership SunLink Health Systems Insider Ownership Mangoceuticals Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Strategy Insiders Buy In While Analysts Predict Big UpsideThe Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months This page (NASDAQ:BDSX) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biodesix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biodesix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
